It's a "gateway to embryo editing to do enhancements." The post Scientists Concerned Latest Gene Editing of Human Embryos ...

Emerging gene editing platforms are revolutionizing precision medicine, enabling safe and effective genetic modifications for ...

Researchers relied on a newer gene-editing technique that may make it possible to engineer embryos, a prospect that has long ...

CRISPR Therapeutics (NasdaqGM:CRSP) filed a large shelf registration, creating capacity to issue new securities over time.

COMMENTARY: Why is this latest development generally being hailed as a scientific milestone rather than a giant ethical ...

The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.

A team in the US has reported promising results after using an improved form of CRISPR to gene-edit human embryos, but a ...

India, June 14 -- Researchers at Amsterdam UMC, working alongside several partner hospitals, have completed the world's first ...

In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows ...

One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

Learn how CRISPR ETFs provide access to the gene-editing revolution, offering investors a diversified approach without picking individual biotech stocks.